Volume 13, Issue 1 (3-2023)                   PCNM 2023, 13(1): 50-58 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohebbi P, Maleki A, Piri M. Pregnancy Outcomes in Pregnant Women with Symptoms of Covid-19 Admitted to Ayatollah Mousavi Hospital in Zanjan in 2019-2020. PCNM 2023; 13 (1) :50-58
URL: http://nmcjournal.zums.ac.ir/article-1-849-en.html
Assistant Professor, Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran , Malekia41@yahoo.com
Abstract:   (2333 Views)
Background: Following the spread of Covid-19 worldwide and the increase in the percentage of pregnant women suffering from the disease, it will be very important to investigate its consequences in pregnancy.
Objectives: The present study was conducted to determine pregnancy outcomes in pregnant women with symptoms of covid-19 admitted to Ayatollah Mousavi Hospital in Zanjan in 2019-2020.
Methods: In this study, the pregnancy outcomes in 89 pregnant women with symptoms of covid-19 admitted to Ayatollah Mousavi Hospital in Zanjan were investigated with document review and file reading. The sampling method was complete enumeration. Maternal and neonatal outcomes were collected using a checklist and analyzed with descriptive statistics in SPSS version 22 Software.
Results: The most common symptoms in hospitalized pregnant women were cough (51.7%) and dyspnea (40.4%). In the laboratory results of pregnant women, leukocytosis, fasting hyperglycemia, increased CRP and alkaline phosphatase were evident. In terms of maternal outcomes, 27% of women had more than one of the examined outcomes. 13.5% had gestational diabetes and 11.2% of mothers had a premature delivery. Regarding neonatal outcomes, fetal heart rate disorder, hospitalization in the neonatal intensive care unit (37.5%), and the need for resuscitation in the first minute (28.1%) were the most reported outcomes.
Conclusion: Considering the increase in adverse maternal and neonatal outcomes in pregnant women with symptoms of covid-19, it is suggested to plan for access to special care to improve the outcomes and implement awareness programs to prevent pregnant mothers from this infection.
Full-Text [PDF 664 kb]   (1509 Downloads)    
Type of Study: Orginal research | Subject: Midwifery
Received: 2022/09/13 | Accepted: 2023/03/1 | Published: 2023/03/1

References
1. 1. Marchand G, Patil AS, Masoud AT, Ware K, King A, Ruther S, et al. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021. AJOG Glob Rep. 2022;2(1):100049-. [Crossref]
2. Sathiya R, Rajendran J, Sumathi S. COVID-19 and Preeclampsia: Overlapping Features in Pregnancy. Rambam Maimonides Med J. 2022;13(1):e0007. [Crossref]
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. [Crossref]
4. Moore KM, Suthar MS. Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun. 2021; 538: 180-86. [Crossref]
5. Matar R, Alrahmani L, Monzer N, Debiane LG, Berbari E, Fares J, et al. Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021;72(3):521-33. [Crossref]
6. Sathiya R, Rajendran J, Sumathi S. COVID-19 and Preeclampsia: Overlapping Features in Pregnancy. Rambam Maimonides Med J. 2022;13(1). [Crossref]
7. Yang Z, Wang M, Zhu Z, Liu Y. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. J Matern Fetal Neonatal Med. 2022; 35(8): 1619-22. [Crossref]
8. Abbas AM, Ahmed OA, Shaltout AS. COVID-19 and maternal pre-eclampsia: A synopsis. Scand J Immunol. 2020; 92(3): e12918. [Crossref]
9. Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022; 226(2): 177-86. [Crossref]
10. Liu H, Wang L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020; 139: 103122. [Crossref]
11. Yang J, D'Souza R, Kharrat A, Fell DB, Snelgrove JW, Shah PS. COVID-19 pandemic and population-level pregnancy and neonatal outcomes in general population: A living systematic review and meta-analysis. Acta obstet gynecol Scand. 2022; 101(3): 273-92. [Crossref]
12. Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. Int J Gynecol Obstet. 2020;150(1):47-52. [Crossref]
13. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016; 16(1): 1-11. [Crossref]
14. Bayat F, Mousavi M, Moradi z, Keshavarz Afshar M, Shahrahmani H. Prevalence of Gestational Diabetes and Its Associated Maternal and Neonatal Outcomes in Women Referred to Ayatollah Mousavi Hospital in Zanjan. PCNM. 2020:6-1. [Crossref]
15. Zhang L, Jiang Y, Wei M, Cheng B, Zhou X, Li J, et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua fu chan ke za zhi. 2020:166-71.
16. Matar R, Alrahmani L, Monzer N, Debiane LG, Berbari E, Fares J, et al. Clinical presentation and outcomes of pregnant women with coronavirus disease 2019: a systematic review and meta-analysis. Clin Infect Dis. 2021; 72(3): 521-33. [Crossref]
17. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(1):36-46. [Crossref]
18. Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020; 252: 490-501. [Crossref]
19. Delahoy MJ, Whitaker M, O'Halloran A, Chai SJ, Kirley PD, Alden N, et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347-54. [Crossref]
20. Wang CL, Liu YY, Wu CH, Wang CY, Wang CH, Long CY. Impact of COVID-19 on Pregnancy. Int J Med Sci. 2021; 18(3): 763-7. [Crossref]
21. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl pediatr. 2020;9(1):51. [Crossref]
22. Delahoy MJ, Whitaker M, O'Halloran A, Chai SJ, Kirley PD, Alden N, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19-COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347. [Crossref]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Preventive Care in Nursing & Midwifery Journal

Designed & Developed by : Yektaweb